Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2023 | Percentile | Sector n |
|---|---|---|---|---|
| Jerarsi | Healthcare Services | 20.2% | 78th pct | 312 |
| Medi Club Georgia | Healthcare Services | 17.2% | 69th pct | 312 |
| S. Khechinashvili Unive… | Healthcare Services | 7.9% | 47th pct | 312 |
| Tbilisi Central Hospital | Healthcare Services | 4.9% | 39th pct | 312 |
| Academician Vakhtang Bo… | Healthcare Services | 0.3% | 28th pct | 312 |
Percentile is within each company's own sector across the whole FY2023 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2023 | Tbilisi Central Hospital | Jerarsi | S. Khechinashvili Unive… | Medi Club Georgia | Academician Vakhtang Bo… |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 19.8% | 74.4% | 76.9% | 32.4% | 77.7% |
| EBITDA Margin | 4.9% | 20.2% | 7.9% | 17.2% | 0.3% |
| EBITDAR | 2,344 | 5,619 | 1,775 | 3,845 | 66 |
| EBITDAR Margin | 4.9% | 20.2% | 7.9% | 17.2% | 0.3% |
| EBIT Margin | 4.6% | 4.1% | 3.6% | 15.3% | -10.8% |
| Net Profit Margin | -25.4% | -6.5% | 1.2% | 12.5% | -10.6% |
| Operating Expense % of Sales | 14.9% | 56.4% | 70.4% | 16.1% | 78.5% |
| Returns | |||||
| Return on Assets (ROA) | -46.9% | -5.5% | 1.6% | 17.4% | -10.1% |
| Return on Equity (ROE) | -80.5% | N/A | 7.2% | 19.8% | -14.2% |
| ROIC [EBIT / Invested Capital] | |||||
| 9.7% |
| 4.6% |
| 7.8% |
| 33.4% |
| -12.1% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 28.8% | 116.9% | 38.1% | 0.0% | 15.5% |
| Debt-to-Equity | 0.49x | -3.30x | 1.73x | 0.00x | 0.22x |
| Debt-to-EBITDA | 3.17x | 6.81x | 3.75x | 0.00x | 48.21x |
| Equity-to-Assets | 58.2% | -35.4% | 22.0% | 88.1% | 71.3% |
| Net Debt | 7,300 | 36,390 | 6,629 | -3,810 | 2,938 |
| Cash & Equivalents | 132 | 1,871 | 21 | 3,810 | 258 |
| Total Debt | 7,432 | 38,261 | 6,650 | N/A | 3,196 |
| Liquidity & working capital | |||||
| Current Ratio | 1.10x | 0.74x | 0.52x | 3.27x | 2.13x |
| Quick Ratio | 0.91x | 0.62x | 0.47x | 2.74x | 1.78x |
| Cash Ratio | 0.02x | 0.11x | 0.00x | 2.00x | 0.09x |
| Total Current Assets | 7,551 | 12,368 | 5,237 | 6,235 | 6,471 |
| Total Current Liabilities | 6,861 | 16,716 | 10,043 | 1,905 | 3,036 |
| Inventory | 1,281 | 2,027 | 551 | 1,014 | 1,078 |
| Trade Receivables | 6,138 | 8,470 | 4,665 | 1,272 | 5,135 |
| Trade Payables | 3,365 | 6,055 | 6,269 | 651 | 2,742 |
| Net Working Capital | 690 | -4,348 | -4,805 | 4,330 | 3,435 |
| Net Working Capital % of Revenue | 1.4% | -15.6% | -21.3% | 19.4% | 17.3% |
| Trade Working Capital | 4,054 | 4,441 | -1,053 | 1,635 | 3,471 |
| Trade Working Capital % of Revenue | 8.5% | 15.9% | -4.7% | 7.3% | 17.5% |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | N/A |
| Turnover & efficiency | |||||
| Inventory Turnover | 29.82x | 3.52x | 9.47x | 14.88x | 4.09x |
| Days Inventory Outstanding (DIO) | 12.2 | 103.8 | 38.6 | 24.5 | 89.2 |
| Receivables Turnover | 7.76x | 3.29x | 4.84x | 17.55x | 3.86x |
| Days Sales Outstanding (DSO) | 47.0 | 111.0 | 75.4 | 20.8 | 94.5 |
| Payables Turnover | 11.35x | 1.18x | 0.83x | 23.18x | 1.61x |
| Days Payable Outstanding (DPO) | 32.1 | 310.2 | 439.0 | 15.7 | 226.9 |
| Cash Conversion Cycle | 27.1 days | -95.4 days | -325.1 days | 29.6 days | -43.1 days |
| Asset Turnover | 1.85x | 0.85x | 1.29x | 1.40x | 0.96x |
| Cash flow & dividends | |||||
| Operating Cash Flow | -1,153 | 814 | 2,677 | 4,594 | 1,915 |
| Free Cash Flow (OCF − Capex proxy) | -2,612 | 923 | 356 | 3,234 | 336 |
| Cash Conversion (OCF / EBITDA) | -49.2% | 14.5% | 150.8% | 119.5% | 2888.7% |
| Dividends Declared | 842 | 0 | 326 | 3,885 | 3,800 |
| Dividend Payout Ratio | N/A | N/A | 117.4% | 139.7% | N/A |